SynCardia denies competitor ’ s market exit claim

SynCardia Systems isn’t exiting the market quite yet, according to a press release posted today in response to a competitor’s claim. Syncardia makes an artificial heart system designed to replace the functions of both the left and right ventricles and all 4 heart valves. “SynCardia’s machine works quite well. But it’s a very old machine with a big air compressor … I’m not surprised that they’re heading out of the market,” said artificial heart developer Carmat’s chief exec Marcello Conviti, according to an article on Seeking Alpha. The company said that it will “emerge from Chapter 11 reorganization” with a new owner, Sindex, on September 16, and went on to contest each point in Conviti’s statement. Syncardia touted the functionality of the device, saying its products account for 1,625 of the total 1,688 artificial hearts that have been implanted since 1969, and said that statistics from an International Society for Heart and Lung Transplantation indicated that 73.5% of patients implanted with the device were either alive or transplanted with a new heart at 6-months, and touted it as the “highest bridge to transplant rate of any durable device.” The company touted upgrades to its air compressor, saying it has received clearance from the FDA, CE Mark approval in the European Union and Health Canada approval for upgrades to the heart, including new drivers and portable drivers, over the l...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Business/Financial News Cardiac Implants Cardiovascular SynCardia Source Type: news

Related Links:

In this issue of Seminars, Jimenez and colleagues1 present their outcomes and repair rates for mitral valve (MV) operations following implementation of a dedicated multidisciplinary heart valve team at a low mitral volume Veterans Administration (VA) hospital. In this retrospective review of 103 consecutive mitral operations performed upon initiation of their heart valve team in 2009, through to 2016, MV repair rates increased to 67% compared to 21% from the previous 8-year period. In this recent era, repair rates for degenerative disease were 86.5% (64/74) with mild or less residual mitral regurgitation (MR) in longitudin...
Source: Seminars in Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: ADULT – Editorial Commentary Source Type: research
(Reuters Health) - In a first, heart surgeons in Poland used 3D goggles to help them see inside a patient's chest as they opened up a narrowed heart valve, according to a report in the European Heart Journal.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Researchers from Israel have created a 3D-printed model that captures the immunological,...Read more on AuntMinnie.comRelated Reading: 3D printing reduces liver transplant costs, surgery time 3D printing helps separate rare case of conjoined twins 3D printing technique improves heart valve sizing 3D-printed aortas could work well for TAVR Flexible 3D-printed heart replicates size, texture
Source: Headlines - Category: Radiology Source Type: news
Discussion Until now, the main tool used for bacterial identification based on NGS of the 16S–23S rRNA encoding region was de novo assembly followed by BLASTN on NCBI database (Sabat et al., 2017), however, there was no evidence that it would be the most accurate and/or fastest method available. The de novo assembly and BLASTN is the only approach of the three that works at the contig level, and both the OTU clustering and mapping are performed at the read level. Using the NCBI database for these two last approaches would have resulted in odd results, since the NCBI database includes sequences that do not belong to ...
Source: Frontiers in Microbiology - Category: Microbiology Source Type: research
Conclusions: Embolism associated with asymptomatic carotid stenosis shows circadian variation with highest rates 4–6 h before midday. This corresponds with peak circadian incidence of stroke and other vascular complications. These and ASED Study results show that monitoring frequency, duration, and time of day are important in ES detection. Introduction Transcranial Doppler (TCD) detected microembolism in the ipsilateral middle cerebral artery (MCA) may help stratify the risk of stroke and other arterial disease complications in persons with advanced (≥60%) asymptomatic carotid stenosis. If so, this techniqu...
Source: Frontiers in Neurology - Category: Neurology Source Type: research
Condition:   Atrial Fibrillation, Venous Thrombosis, Heart Valve Diseases Interventions:   Other: Fearon warfarin dosing algorithm;   Other: Usual care Sponsors:   University of Utah;   Roche Diagnostics Recruiting
Source: - Category: Research Source Type: clinical trials
The objective was to investigate the effect of individualised follow-up after open heart valve surgery on a composite endpoint of first unplanned cardiac hospital readmission or all-cause mortality within 180  days of discharge.
Source: International Journal of Cardiology - Category: Cardiology Authors: Source Type: research
Publication date: Available online 9 April 2019Source: Journal of Cardiology CasesAuthor(s): Toshinori Komatsu, Hirohiko Motoki, Koichiro Kuwahara
Source: Journal of Cardiology Cases - Category: Cardiology Source Type: research
Rolling Stones frontman Mick Jagger’s recent surgery is putting a huge spotlight on the transcatheter aortic valve replacement (TAVR) market. Late last week, Jagger tweeted that his procedure was a success and thanked fans for their support.   Thank you everyone for all your messages of support, I’m feeling much better now and on the mend - and also a huge thank you to all the hospital staff for doing a superb job. — Mick Jagger (@MickJagger) April 5, 2019 Problems for the 75-year-old began late last month after the rocker fell ill. As a result, the Rolling...
Source: MDDI - Category: Medical Devices Authors: Tags: Cardiovascular Source Type: news
Guillaume Goudot1, Tristan Mirault2,3, Patrick Bruneval2,4, Gilles Soulat5, Mathieu Pernot1 and Emmanuel Messas2,3* 1INSERM U1273, ESPCI Paris, CNRS FRE 2031, Physics for Medicine Paris, PSL Research University, Paris, France 2Centre de Référence des Maladies Vasculaires Rares, Hôpital Européen Georges-Pompidou, Assistance Publique – Hôpitaux de Paris (APHP), Paris, France 3INSERM U970 PARCC, Paris Descartes University – Sorbonne Paris Cité University, Paris, France 4Service d’Anatomie Pathologique, Hôpital Européen Georges-Pompidou, Assistanc...
Source: Frontiers in Physiology - Category: Physiology Source Type: research
More News: Cardiology | Cardiovascular | Health | Heart | Heart Transplant | Heart Valve Disease | Heart Valve Surgery | Heart Valves | Legislation | Lung Transplant | Medical Devices | Statistics | Transplant Surgery | Transplants